Abingdon Health Share Discussion Threads

[muck166] 18/6/2025 17:29:10

Just musing today…

One of the biggest cyber concerns is threat actors using AI agents to accelerate attack frequency and sophistication.

We are “codifying the priesthood”, ie creating AI cyber defence agents imbued with Narf expertise.

That must have value in and of itself.

[tia01] 10/7/2024 08:42:41

So after yesterday does anyone believe a discounted share placement coming!. Revenue growing but cash pile reducing.
I’d say definitely a cash raise somewhere to fund expansion.
Cash is king

[z1co] 17/5/2024 13:23:55

CEO speaking to Proactive after the interim results:

[z1co] 17/5/2024 13:20:30

Proactive Investors:

Abingdon Health CEO discusses strong interim results, robust pipeline and growth strategy

Published: 10:38 15 Mar 2024 GMT

Yates said a 117% revenue increase to £2.4 million during the interim period was primarily driven by its CDMO division. This growth was attributed to increases in development, operational revenues, and the emergence of regulatory area revenues.

Despite an inflationary environment, Abingdon Health managed to maintain stable operating costs, resulting in improved gross margins to over 50%.

The company has a robust opportunity pipeline with 29 ongoing projects, emphasizing its fully integrated solution's appeal to customers. Yates also highlighted a good start to the second half of the year, with revenues expected to grow significantly while controlling costs to enhance operating profit performance.

[z1co] 17/5/2024 12:59:16

York, U.K. 15th May 2024: Abingdon Health plc (AIM: ABDX), a leading international lateral flow Contract Development and Manufacturing Organisation (CDMO), announces the launch of Boots own-brand, saliva pregnancy self-test across the UK and online, in partnership with Salignostics and Crest Medical.


On 20th March 2024, Abingdon Health announced the launch of the first two Boots branded self-tests - Iron and Vitamin D deficiency - in-store and online at boots.com.


In another step toward strengthening this partnership with Boots, Abingdon Health is now pleased to announce the launch of the first ever saliva pregnancy test under the Boots own brand range. The test is being made available in store and online at boots.com from Spring 2024 onwards. This product launch allows more people to access a new way of testing for pregnancy.


With the UK pregnancy self-test market expected to reach USD $56.7 million by 20331, this provides a strategic opportunity to launch, on an own-brand basis, an innovative product in this growing market with the UK's leading health and beauty retailer. With general consumer adoption of self-tests on the rise (US $7.89 billion in 2023)2, and a robust pipeline of products within its CRO/CDMO offering, Abingdon Health is well positioned to continue developing OEM retail relationships within the UK and Europe as a value-add, innovative Private Label Supplier (PLS).

[z1co] 17/5/2024 12:57:38

!FOLLOWFEED
Launch of the Saliva Pregnancy self-test in Boots

Boots will be the first retailer to sell the world's first saliva pregnancy self-test under its own brand label

Tests will be available in Boots stores and online across the UK provided by Abingdon Health, Salignostics and Crest Medical partnership

[highrisk1] 20/3/2024 08:18:35

And were by chance called Bobdown1 before?.

[highrisk1] 20/3/2024 08:17:48

What's nice about it?, Bob.

[bobdown2] 20/3/2024 07:08:17

Nice to see abindon recovering from the tory debacle. Nice rns.

[daz] 15/3/2024 15:26:26

Timbo

I thought the outlook statement was very misleading. Last year ABDX had a strong H2 weighting and it looks to be the same this year, so to say H2 will be materially ahead of H1 is meaningless. A comparison with H2 last year would have given investors a much better insight. Growth will not be 116% in H2 but I want to know
1. Will it be positive and
2. If positive, by roughly how much 20/30/40% etc.
Also, the cash outflow in H1 was £1.238m and they only have £2m cash left. While the burn rate will be lower in H2, without better guidance, it becomes impossible for private investors to make an informed view on the H2 outflow. No doubt Brokers will have been greater insight but it's not much help to me.
Based on the lack of clarity, I can't dismiss the need for another fund raise.

[dennisbergkamp] 14/3/2024 12:39:15

Timbo,

I’ll join you tomorrow

[timbo003] 14/3/2024 11:30:33

How times change!

* Confirmation today that no additional funding required
* Robust current trading
* top of the leader board today
* Last (very substantial) director purchases (at the last placing) were at level 2.5 X the current share price

and no comments?

[timbo003] 14/3/2024 08:22:52

Note "without the need for additional funding"

[timbo003] 14/3/2024 08:21:52

From today's statement:

[timbo003] 17/1/2024 09:40:36

Recording from the Proactive event last week now available:

[timbo003] 23/12/2023 12:35:11

A date for your diaries and a chance to meet the company management if you in or around the London area on January 11th:

[blackhorse23] 16/10/2023 11:44:41

Switched to APH

[timbo003] 14/10/2023 14:42:05

Register for the seminar mentioned in the previous post (which includes a presentation from ABDX) here:

[sharesoc] 14/10/2023 11:45:03

ShareSoc is holding its first hybrid event in London on 19th Oct. Hear from Abingdon Health (ABDX) and other healthcare companies like Tristel Plc (TSTL), Inspiration Healthcare Group (IHC), Creo Medical Group (CREO) and GENincode (GENI). Attend in-person or online.📍7760; Register: [...]

[greenfingerz] 16/8/2023 14:06:58

Looks that way....
SalistickTM is the first rapid saliva-based pregnancy test with a new and improved user-experience, and high accuracy for early pregnancy detection. The kit is based on our revolutionary technology which detects the pregnancy hormone β-hCG in saliva.

[awise355] 16/8/2023 12:27:02

Is this the only one uk or global like it?

[smackeraim] 16/8/2023 12:09:14

SaliStick test kit, received the CE mark from the European authorities and is currently working towards receiving FDA approval in the U.S.Saliva-based pregnancy test: 'Self-Testing Anywhere, by Anyone'"With SaliStick, a pregnancy test can be done anywhere and at any convenient time", says Salignostics."Saliva is the key to rapid diagnostics for a variety of medical reasons. It is the only non-invasive, easy, and hygienic means to detect hormones, viruses, and even diseases," adds Prof. Aaron Palmon, co-founder of Salignostics.This product completely removes the need for blood and urine samples when testing for pregnancy"With SaliStick, we leverage the powerful diagnostics abilities we have been able to create from analyzing saliva. This product completely removes the need for blood and urine samples when testing for pregnancy."Salignostics claims that the process is straightforward, easy to use and provides accurate results within a few minutes. It also boasts that the test can be done more conveniently and without needing a bathroom.